In further support to the tumor suppressor effects and decreased expression of Wnt5a in breast cancer, it has been implicated that loss of Wnt5a expression directly correlates with advancing TNM, decreasing survival and triple-negative status in both sporadic and heredity breast cancer tissues [37]. This evidence concerns the gene WNT5A and breast carcinoma.